Point-of-Care Testing Clinical Trials
2 recruiting trials for Point-of-Care Testing. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Point-of-Care Testing clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of Sao Paulo (1), MagIA Diagnostics (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Point-of-care ultrasensitive troponin testing (diagnostic_test, 1 trial), followed by Laboratory-based ultrasensitive troponin testing.
Track Point-of-Care Testing trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Effect of Point-of-care Analysis of Ultrasensitive Troponin I on Length of Hospital Stay in Patients With Cardiac Chest...
This clinical study aims to compare two different methods for measuring high-sensitivity troponin I, a key biomarker used to diagnose heart attacks. The primary research question...
Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)
Performance study to evaluate the clinical performance of the In-Vitro Diagnostics Medical Device MagIA H3S (a Multiplex Point-of-Care test for the combined detection of Human...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Point-of-Care Testing, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Point-of-Care Testing, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Point-of-Care Testing, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.